MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/bloodadvances.2022008510

Медицинская библиотека · Blood advances · 2023

Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome.

Katzerke Christiane, Schaffrath Judith, Lützkendorf Jana, Janssen Maike, Merbach Anne-Kathrin, Nerger Katrin, Binder Mascha, Baum Cornelia, Lauer Kirstin, Rohde Christian, Willscher Edith, Müller-Tidow Carsten, Müller Lutz P

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Engraftment and differentiation of donor hematopoietic stem cells is decisive for the clinical success of allogeneic stem cell transplantation (alloSCT) and depends on the recipient's bone marrow (BM) niche. A damaged niche contributes to poor graft function after alloSCT; however, the underlying mechanisms and the role of BM multipotent mesenchymal stromal cells (MSC) are ill-defined. Upon multivariate analysis in 732 individuals, we observed a reduced presence of proliferation-capable MSC in BM aspirates from patients (N = 196) who had undergone alloSCT. This was confirmed by paired analysis in 30 patients showing a higher frequency of samples with a lack of MSC presence post-alloSCT compared with pre-alloSCT. This reduced MSC presence was associated with reduced survival of patients after alloSCT and specifically with impaired graft function. Post-alloSCT MSC showed diminished in vitro proliferation along with a transcriptional antiproliferative signature, upregulation of epithelial-mesenchymal transition and extracellular matrix pathways, and altered impact on cytokine release upon contact with hematopoietic cells. To avoid in vitro culture bias, we isolated the CD146+/CD45-/HLA-DR- BM cell fraction, which comprised the entire MSC population. The post-alloSCT isolated native CD146+MSC showed a similar reduction in proliferation capacity and shared the same antiproliferative transcriptomic signature as for post-alloSCT colony-forming unit fibroblast-derived MSC. Taken together, our data show that alloSCT confers damage to the proliferative capacity of native MSC, which is associated with reduced patient survival after alloSCT and impaired engraftment of allogeneic hematopoiesis. These data represent the basis to elucidate mechanisms of BM niche reconstitution after alloSCT and its therapeutic manipulation.

Для цитирования: Katzerke Christiane, Schaffrath Judith, Lützkendorf Jana, Janssen Maike, Merbach Anne-Kathrin, Nerger Katrin, Binder Mascha, Baum Cornelia, Lauer Kirstin, Rohde Christian, Willscher Edith, Müller-Tidow Carsten, Müller Lutz P. Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome.. Blood advances. 2023. DOI: 10.1182/bloodadvances.2022008510.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.